Tanezumab and Nerve Function In Arthritis Patients

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Osteoarthritis

In brief

Tanezumab reduces pain of osteoarthritis without affecting how nerve impulses are transmitted in sensory nerves.

Key facts

Study ID
NCT00863772
Run by
Pfizer
People needed
220
Starts
2009-05-18
Expected to finish
2010-11-16
Last updated by the study team
2021-02-04

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.